New device aims to measure blood oxygen without needles

NCT ID NCT07503171

Not yet recruiting Knowledge-focused Sponsor: Nihon Kohden Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new noninvasive device that measures oxygen and hemoglobin levels in 7 healthy adults. Participants will be exposed to controlled low oxygen and blood dilution to see how well the device works compared to standard blood tests. The goal is to improve monitoring technology for future patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Noninvasive Physiological Monitoring Device (Octopal R DMO-8000X with TL 811S Finger Probe)
What this could lead to: If successful, this could lead to better noninvasive monitors for oxygen and hemoglobin levels, improving patient care in hospitals.
What could go wrong: This is a very small, early-stage study with only 7 healthy volunteers. Results may not apply to sick patients, and the device may not perform as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMODILUTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODILUTION HYPOXIA

Contacts and locations

Locations

Vital Sign Research Group

San Francisco, California, 94107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.